Indications and uses
relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn do not use more than 2 tablets in 24 hours children under 12 years: ask a doctor
store at 20° to 25° C (68° to 77° F) protect from moisture read the directions and warnings before use keep the carton. It contains important information.
Drug Facts
Famotidine, USP 20 mg
Acid reducer
Do not use if you are allergic to famotidine or other acid reducers
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, pregelatinized starch, talc, titanium dioxide
call 1-800-406-7984
Distributed By:
Pharmacy Value Alliance, LLC
407 East Lancaster Avenue,
Wayne, PA 19087
†COMPARE TO THE ACTIVE INGREDIENT
IN MAXIMUM STRENGTH PEPCID AC®
Premier
Value ®
MAXIMUM STRENGTH
Famotidine Tablets, USP 20 mg
Acid Controller
Acid Reducer
25 Tablets
INDEPENDENTLY TESTED
PV
SATISFACTION GUARANTEED

| Class | Version | Type | Effective |
|---|---|---|---|
| FAMOTIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae | Product name | 7 | 20260317 |
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| cf645750-2e70-f6e1-c05a-a52847def5dd | Product name | 9 | 20250312 |
| 4fdc761c-585e-054b-8ebe-86130a26e4c1 | Product name | 2 | 20221205 |
| fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68016-008-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-59c0-d83d-e063-dadaa90ab31f | Premier Value ® Famotidine |
| 68016-010-81 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-59c0-d83d-e063-dadaa90ab31f | Premier Value ® Famotidine |
| 68016-010-82 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-59c0-d83d-e063-dadaa90ab31f | Premier Value ® Famotidine |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68016-008-01 | Premier Value Famotidine | 25 in 1 BOTTLE | TABLET, FILM COATED | 25 | 4 | |
| 68016-010-81 | Premier Value Famotidine | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 4 | |
| 68016-010-82 | Premier Value Famotidine | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68016-008 | PREMIER VALUE FAMOTIDINE (FAMOTIDINE) TABLET, FILM COATED [PREMIER VALUE] | 4 | Legacy NDC, 1 package rows | 20191231_42d1e2f2-9b9b-4a6d-9fc1-047e167153b5.zip |
| 68016-010 | PREMIER VALUE FAMOTIDINE (FAMOTIDINE) TABLET, FILM COATED [PREMIER VALUE] | 4 | Legacy NDC, 2 package rows | 20191231_42d1e2f2-9b9b-4a6d-9fc1-047e167153b5.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68016-010-81 | EA - Each | 68016-010 | fb9f6589-7c04-42e0-92ff-5bdab43844ac | 1 | 2022-06-06 |
| 68016-010-82 | EA - Each | 68016-010 | 9fe6c8b1-e77b-4fe3-a1a9-658699c603f5 | 1 | 2022-06-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | 1 | |
| STARCH, PREGELATINIZED CORN | INACTIVE INGREDIENT | O8232NY3SJ | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68016-010 | 68016-010-81, 68016-010-82 |
| 68016-008 | 68016-008-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM / BUCCAL | 3 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | INSERT / VAGINAL | 147 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, FILM COATED / ORAL | 131.67 mg | ||
| COLLOIDAL SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| COLLOIDAL SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 42 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SPONGE / TOPICAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / ORAL | 72 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| COLLOIDAL SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | CAPSULE, LIQUID FILLED / ORAL | 1122 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION/ DROPS / ORAL | 90 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | TABLET, DELAYED RELEASE / ORAL | 35 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | OINTMENT / TOPICAL | 1950 mg | ||
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET / SUBLINGUAL | 1 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| COLLOIDAL SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | POWDER / ORAL | 244 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | INJECTION / INTRAVENOUS | 28216 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SHAMPOO / TOPICAL | 3 %w/w | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| COLLOIDAL SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | POWDER, FOR SUSPENSION / ORAL | 1 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED / ORAL | 0.12 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET, CHEWABLE / ORAL | 180 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SYRUP / ORAL | 740 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, DELAYED RELEASE / ORAL | 216 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | JELLY / TOPICAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | CONCENTRATE / ORAL | NA | ||
| COLLOIDAL SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SUPPOSITORY / RECTAL | 0.25 mg/mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| HYDROXYPROPYL CELLULOSE | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | SOLUTION / TOPICAL | 200 mg | ||
| COLLOIDAL SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SWAB / TOPICAL | 5250 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET / SUBLINGUAL | 409 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED PELLETS / ORAL | 4.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090283-001 | FAMOTIDINE | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | ||
| A090283-002 | FAMOTIDINE | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090283-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2009-11-17 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090283-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2009-11-17 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7ab337e1-90e1-4233-b854-19aee40ccfbe | 42d1e2f2-9b9b-4a6d-9fc1-047e167153b5 | 2019-12-27 | Warnings | 7ab337e1-90e1-4233-b854-19aee40ccfbe 42d1e2f2-9b9b-4a6d-9fc1-047e167153b5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.